(1) Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 2014 -3-15;3(1):R13-R30.
(2) Javaid MK, Boyce A, Appelman-Dijkstra N, Ong J, Defabianis P, Offiah A, et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019 06 13,;14(1):139.
(3) Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe AD, et al. Osteogenesis imperfecta. Nature Reviews Disease Primers 2017 -08-18;3(1):1-19.
(4) Tallon D, Chard J, Dieppe P. Relation between agendas of the research community and the research consumer. Lancet 2000 Jun 10,;355(9220):2037-2040.
(5) Liberati A. Need to realign patient-oriented and commercial and academic research. The Lancet 2011 /11/19;378(9805):1777-1778.
(6) Thornton H. Patient and public involvement in clinical trials. BMJ 2008 -4-26;336(7650):903-904.
(7) Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J, Gülmezoglu AM, et al. How to increase value and reduce waste when research priorities are set. The Lancet 2014 /01/11;383(9912):156-165.
(8) Mockford C, Staniszewska S, Griffiths F, Herron-Marx S. The impact of patient and public involvement on UK NHS health care: a systematic review. Int J Qual Health Care 2012 Feb;24(1):28-38.
(9) Partridge N, Scadding J. The James Lind Alliance: patients and clinicians should jointly identify their priorities for clinical trials. Lancet 2004 Nov 27-Dec 3;364(9449):1923-1924.
(10) JLA Guidebook | James Lind Alliance. Available at: www.jla.nihr.ac.uk/jla-guidebook/. Accessed Jan 8, 2020.
(11) Crowe S, Fenton M, Hall M, Cowan K, Chalmers I. Patients', clinicians' and the research communities' priorities for treatment research: there is an important mismatch. Res Involv Engagem 2015;1:2.
(12) The PSPs | James Lind Alliance. Available at: www.jla.nihr.ac.uk/priority-setting-partnerships/. Accessed Jan 8, 2020.
(13) Rangan A, Upadhaya S, Regan S, Toye F, Rees JL. Research priorities for shoulder surgery: results of the 2015 James Lind Alliance patient and clinician priority setting partnership. BMJ Open 2016 -4-11;6(4).
(14) Davies BM, Khan DZ, Mowforth OD, McNair AGK, Gronlund T, Kolias AG, et al. RE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): A Consensus Process to Improve Research Efficiency in DCM, Through Establishment of a Standardized Dataset for Clinical Research and the Definition of the Research Priorities: Global Spine Journal 2019 May 8,.
(15) Sheehan WJ, Williams MA, Paskins Z, Costa ML, Fernandez MA, Gould J, et al. Research priorities for the management of broken bones of the upper limb in people over 50: a UK priority setting partnership with the James Lind Alliance. BMJ Open 2019 Dec 15,;9(12):e030028.
(16) Fernandez MA, Arnel L, Gould J, McGibbon A, Grant R, Bell P, et al. Research priorities in fragility fractures of the lower limb and pelvis: a UK priority setting partnership with the James Lind Alliance. BMJ Open 2018 10 03,;8(10):e023301.
(17) Schoemaker CG, Armbrust W, Swart JF, Vastert SJ, van Loosdregt J, Verwoerd A, et al. Dutch juvenile idiopathic arthritis patients, carers and clinicians create a research agenda together following the James Lind Alliance method: a study protocol. Pediatr Rheumatol Online J 2018 Sep 15,;16(1):57.
(18) Rare Musculoskeletal Diseases in Adulthood | James Lind Alliance. Available at: www.jla.nihr.ac.uk/priority-setting-partnerships/rare-musculoskeletal-diseases-in-adulthood/rare-musculoskeletal-diseases-in-adulthood.htm. Accessed Jan 10, 2020.
(19) Top 10s of priorities for research | James Lind Alliance. Available at: www.jla.nihr.ac.uk/top-10-priorities/. Accessed Jan 11, 2020.
(20) Rare Inherited Anaemias | James Lind Alliance. Available at: www.jla.nihr.ac.uk/priority-setting-partnerships/rare-inherited-anaemias/. Accessed Jan 11, 2020.
(21) Davila-Seijo P, Hernández-Martín A, Morcillo-Makow E, de Lucas R, Domínguez E, Romero N, et al. Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders. Orphanet J Rare Dis 2013 Apr 22,;8:61.
(22) Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ. What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals. BMJ Open 2019 03 15,;9(3):e026573.
(23) Thomas IH, DiMeglio LA. Advances in the Classification and Treatment of Osteogenesis Imperfecta. Curr Osteoporos Rep 2016 Feb;14(1):1-9.
(24) Robinson C, Collins MT, Boyce AM. Fibrous Dysplasia/McCune-Albright Syndrome: Clinical and Translational Perspectives. Curr Osteoporos Rep 2016 10;14(5):178-186.
(25) Carpenter TO, Imel EA, Holm IA, Jan de Beur, Suzanne M., Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res 2011 Jul;26(7):1381-1388.